TABLE 4.
Treatment group |
|||||
Vitamin | AI, μg/L | Control (n = 177) | LNS (n = 185) | ARV (n = 85) | ARV + LNS (n = 90) |
Thiamin,2 % | |||||
2 or 6 wk | 200 | 35 | 35 | 31 | 36 |
24 wk | 200 | 50 | 56 | 52 | 50 |
Riboflavin,3 % | |||||
2 or 6 wk | 350 | 0 | 3.2 | 0 | 0 |
24 wk | 350 | 0.6 | 1.6 | 1.2 | 1.1 |
Nicotinamide, % | |||||
2 or 6 wk | 1800 | 2.8 | 5.4 | 1.2 | 1.1 |
24 wk | 1800 | 0 | 1.6 | 0 | 1.1 |
Pyridoxal, % | |||||
2 or 6 wk | 130 | 9.0 | 17 | 5.9 | 7.8 |
24 wk | 130 | 36 | 60 | 44 | 41 |
Vitamin B-12, % | |||||
2 or 6 wk | 0.42 | 35 | 47 | 33 | 33 |
24 wk | 0.42 | 16 | 34 | 17 | 22 |
AI, Adequate Intake; ARV, antiretroviral; LNS, lipid-based nutrient supplement; n, number of samples.
Thiamin = thiamin + (thiamin monophosphate × 0.871) + (thiamin pyrophosphate × 0.707).
Riboflavin = riboflavin + (flavin adenine dinucleotide × 0.479).